Devonian Health Group is trading at $9.00, +12.50%, amid plans for a potential NYSE American listing.
- On September 11, 2026, the company announced its shares and warrants could begin trading on NYSE American as early as September 16, 2026.
- The planned underwritten offering, proposed U.S. listing, and potential TSXV ticker change to DHGR provide a clear company-specific catalyst.
- Devonian Health Group is expected to remain listed on TSXV, subject to final exchange authorization and compliance.